Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Peripheral Analgesic Effects
NCT04431206Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Nov 2020
- Primary completion
- Nov 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in osteoarthritis (OA), sponsored by Wake Forest University Health Sciences. Started Nov 2020; status: terminated.
02
Drugs
oxytocin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04431206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04431206.